Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA.
The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
A transferrin receptor-targeted antibody transport vehicle improved brain distribution and reduced ARIA-like lesions in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
SciPy 1.0: fundamental algorithms for scientific computing in Python
Virtanen, P., Gommers, R., Oliphant, T. E., Haberland, M., Reddy, T., Cournapeau, D., Burovski, E., Peterson, P., Weckesser, W., Bright, J., et al. (2020) · Nature Methods · doi:10.1038/s41592-019-0686-2 · Cited by 38,430
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
scikit-image: image processing in Python
van der Walt, S., Schönberger, J. L., Nunez-Iglesias, J., Boulogne, F., Warner, J. D., Yager, N., Gouillart, E., & Yu, T. (2014) · PeerJ · doi:10.7717/peerj.453 · Cited by 6,794
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Self-citationBard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Research works printed but not linked: 2
- T. Bussiere J. Abettan J. Sebalusky S. Hamann A. Silva Amaral D. Walsh D. Bradley E. Plowey “Modeling mechanisms of amyloid-related imaging abnormalities (aria) in transgenic mice treated with anti-aβ immunotherapy and imaged with MRI.” abstract #425 oral presentation at AD/PD 5-9 March 2024 Lisbon Portugal [Preprint] (2024); https://cslide.ctimeetingtech.com/adpd24/attendee/confcal/show/session/14#presentation-abstract-42585247580.
- V. O. Torres M. E. Pizzo D. Chan J. C. Dugas D. Huynh D. Joy E. K. Liang L. Sarrafha I. Becerra R. Chau K. S. Chew J. Chow T. K. Earr N. Khoury K. J. Lechtenberg A. W. Leung H. N. Nguyen E. S. Ojo E. Roche H. Solanoy M. Tong R. K. Tong K. Henne J. W. Lewcock R. J. Watts M. E. Calvert R. G. Thorne Y. J. Y. Zuchero Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development but maintained across adult aging. BioRxiv 10.1101/2024.11.12.623253 [Preprint] (2024); https://doi.org/10.1101/2024.11.12.623253.10.1101/2024.11.12.623253 · DOI
Cited by
Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier
Boado, R. J. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00204d · Cited by 23
de Weerd, L., Hummel, S., Müller, S. A., Paris, I., Sandmann, T., Eichholtz, M., Gröger, R., Englert, A. L., Wagner, S., Ha, C., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00878-1 · Cited by 20
“Whether this phenotype could be related to the hTfR KI [48] in these mice is unclear, however another study using 5xFAD; hTfR KI mice did not observe any spontaneous microbleeds without anti-Aβ antibody treatment [44].”
Self-citationAmyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets
Ahmadi, S., Khaledi, S., Ahmadi, K., & Hassanzadeh, K. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70688 · Cited by 22
“Pizzo et al. [266] recently developed an antibody transport vehicle that targets the transferrin receptor to deliver Aβ antibodies to the brain.”
Serrano‐Pozo, A., Escott‐Price, V., Grinberg, L. T., Pascoal, T. A., Suárez‐Calvet, M., Dubois, B., & Sperling, R. A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00198-4 · Cited by 21
Li, J., Guo, L., Cai, W., Mei, J., Liu, J., & Liu, Y. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2645830 · Cited by 21
“Recent studies have employed a ‘Trojan horse’ strategy, utilizing transferrin receptors on cerebrovascular endothelial cells as natural conduits to help antibodies enter the brain parenchyma more precisely and safely (Pizzo et al. 2025).”
Metadata
- Authors
- Pizzo, M. E., Plowey, E. D., Khoury, N., Kwan, W., Abettan, J., DeVos, S. L., Discenza, C. B., Earr, T., Joy, D., Lye-Barthel, M., Roche, E., Chan, D., Dugas, J. C., Gadkar, K., Hamann, S., Meisner, R., Sebalusky, J., Silva Amaral, A. C., Becerra, I., Chau, R., Chow, J., Clemens, A. J., Dennis, M. S., Duque, J., Fusaro, L., Getz, J. A., Kariolis, M. S., Kim, D. J., Lechtenberg, K. J., Leung, A. W.-S., Moshkforoush, A., Nguyen, H. N., Ojo, E. S., Thomsen, E. R., Torres, V. O., Sanchez, P. E., Shan, L., Silverman, A. P., Sweeney, Z. K., Solanoy, H., Tong, R., Calvert, M. E., Watts, R. J., Thorne, R. G., Weinreb, P. H., Walsh, D. M., Lewcock, J. W., Bussiere, T., & Zuchero, Y. J. Y.
- Affiliations
- Denali Therapeutics (United States) (US)
- Biogen (United States) (US)
- Biogen, Cambridge, MA, USA.
- Denali Therapeutics, Inc., South San Francisco, CA, USA.
- University of Minnesota (US)
- Corresponding author
- Zuchero, Y. Joy Yu
- ORCID
- Pizzo, Michelle E.
- Plowey, Edward D.
- Abettan, Jordan
- DeVos, Sarah L.
- Discenza, Claire B.
- Earr, Timothy
- Joy, David
- Chan, Darren
- Dugas, Jason C.
- Gadkar, Kapil
- Hamann, Stefan
- Meisner, René
- Sebalusky, Jennifer
- Silva Amaral, Ana Claudia
- Chau, Roni
- Chow, Johann
- Dennis, Mark S.
- Duque, Joseph
- Fusaro, Laura
- Getz, Jennifer A.
- Kariolis, Mihalis S.
- Kim, Do Jin
- Lechtenberg, Kendra J.
- Leung, Amy Wing-Sze
- Moshkforoush, Arash
- Nguyen, Hoang N.
- Thomsen, Elliot R.
- Torres, Vanessa O.
- Sanchez, Pascal E.
- Shan, Lu
- Silverman, Adam P.
- Sweeney, Zachary K.
- Solanoy, Hilda
- Tong, Raymond
- Calvert, Meredith E.
- Watts, Ryan J.
- Thorne, Robert G.
- Weinreb, Paul H.
- Walsh, Dominic M.
- Lewcock, Joseph W.
- Bussiere, Thierry
- Zuchero, Y. Joy Yu
- Venue
- Science
- Published
- 2025-08-07
- Volume
- 389
- Issue
- 6760
- Pages
- eads3204-eads3204
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4413045841
- Cited by
- 63
- References
- 73
- Citations by year
- 2026: 49 · 2025: 14
- FWCI
- 40.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- amyloid-related imaging abnormalities, anti-amyloid therapy, transferrin receptor, amyloid-beta immunotherapy, brain drug delivery, blood-brain barrier, Alzheimer's disease, vascular inflammation, amyloid plaques, antibody biodistribution
- MeSH terms
- Alzheimer Disease, Animals, Antibodies, Monoclonal, Blood-Brain Barrier, Brain, Humans, Immunoglobulin Fc Fragments, Magnetic Resonance Imaging, Mutation, Receptors, Transferrin, Tissue Distribution, Amyloid beta-Peptides, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. https://app.cochat.ai/papers/10.1126/science.ads3204
- The paper
- Pizzo, M. E., Plowey, E. D., Khoury, N., Kwan, W., Abettan, J., DeVos, S. L., Discenza, C. B., Earr, T., Joy, D., Lye-Barthel, M., Roche, E., Chan, D., Dugas, J. C., Gadkar, K., Hamann, S., Meisner, R., Sebalusky, J., Silva Amaral, A. C., Becerra, I., . . . Zuchero, Y. J. Y. (2025). Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA. Science. https://doi.org/10.1126/science.ads3204
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.